Using simulated case-control datasets, we show that the case-control LR method using age-specific breast cancer ORs from high-penetrance genes (e.g., BRCA1 and BRCA2) outperforms other OR analysis methods. The gene discussed is BRCA1; the disease is breast carcinoma.